Clinical Trials

Showing trials with last updates posted in 2026.

NCT05456191 | ACTIVE_NOT_RECRUITING | PHASE3
568 participants

A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2022-11-21
Completion:
2025-05-15
Conditions
  • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Interventions
  • DRUG
NCT05438368 | NOT_YET_RECRUITING | PHASE1/PHASE2
30 participants

GD2/CD70 Bi-specific CAR-T Cell Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2026-12-31
Completion:
2029-12-31
Conditions
  • Cancer Disease
Interventions
  • BIOLOGICAL
No Results Yet
NCT05436496 | NOT_YET_RECRUITING | PHASE1/PHASE2
30 participants

CD19/70 Bi-specific CAR-T Cell Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2027-06-01
Completion:
2029-12-31
Conditions
  • B Cell Malignancies
Interventions
  • BIOLOGICAL
No Results Yet
NCT05432882 | NOT_YET_RECRUITING | PHASE1/PHASE2
60 participants

CD19/22 Bi-specific CAR-T Cell Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2027-06-01
Completion:
2029-12-31
Conditions
  • B Cell Malignancies
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page